L.M. Kohn & Company Sells 28,211 Shares of Johnson & Johnson $JNJ

L.M. Kohn & Company trimmed its position in shares of Johnson & Johnson (NYSE:JNJ) by 81.9% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 6,249 shares of the company’s stock after selling 28,211 shares during the quarter. L.M. Kohn & Company’s holdings in Johnson & Johnson were worth $954,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of JNJ. Brighton Jones LLC boosted its stake in Johnson & Johnson by 13.9% during the fourth quarter. Brighton Jones LLC now owns 51,876 shares of the company’s stock worth $7,502,000 after buying an additional 6,332 shares during the period. Wealth Group Ltd. purchased a new position in Johnson & Johnson during the first quarter worth $218,000. Cornerstone Advisors Asset Management LLC boosted its stake in Johnson & Johnson by 11.8% during the first quarter. Cornerstone Advisors Asset Management LLC now owns 3,327 shares of the company’s stock worth $552,000 after buying an additional 352 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its stake in Johnson & Johnson by 0.9% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 6,044,313 shares of the company’s stock worth $1,002,389,000 after buying an additional 52,961 shares during the period. Finally, Little House Capital LLC boosted its stake in Johnson & Johnson by 53.5% during the first quarter. Little House Capital LLC now owns 28,711 shares of the company’s stock worth $4,761,000 after buying an additional 10,007 shares during the period. 69.55% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. Daiwa Capital Markets upgraded shares of Johnson & Johnson from a “neutral” rating to an “outperform” rating and set a $203.00 price target on the stock in a report on Monday, October 20th. JPMorgan Chase & Co. upped their price target on shares of Johnson & Johnson from $185.00 to $200.00 and gave the stock a “neutral” rating in a report on Tuesday, September 16th. Johnson Rice set a $190.00 price target on shares of Johnson & Johnson and gave the stock a “hold” rating in a report on Wednesday, October 22nd. The Goldman Sachs Group upped their price target on shares of Johnson & Johnson from $186.00 to $212.00 and gave the stock a “buy” rating in a report on Thursday, October 9th. Finally, Sanford C. Bernstein upped their price target on shares of Johnson & Johnson from $172.00 to $193.00 and gave the stock a “market perform” rating in a report on Monday, October 6th. Three analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $199.05.

Johnson & Johnson Stock Down 1.8%

NYSE:JNJ opened at $186.94 on Wednesday. Johnson & Johnson has a 1-year low of $140.68 and a 1-year high of $194.48. The company has a 50-day moving average of $182.72 and a 200 day moving average of $166.92. The firm has a market cap of $450.40 billion, a PE ratio of 18.04, a price-to-earnings-growth ratio of 2.24 and a beta of 0.40. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.07 and a quick ratio of 0.80.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings data on Wednesday, August 30th. The company reported $2.26 earnings per share for the quarter. Johnson & Johnson had a net margin of 27.26% and a return on equity of 32.73%. The company had revenue of $24.02 billion during the quarter. As a group, research analysts anticipate that Johnson & Johnson will post 10.58 EPS for the current fiscal year.

Johnson & Johnson Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 25th will be paid a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, November 25th. This represents a $5.20 dividend on an annualized basis and a yield of 2.8%. Johnson & Johnson’s dividend payout ratio is 50.19%.

Insiders Place Their Bets

In related news, EVP Jennifer L. Taubert sold 56,471 shares of the company’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $177.81, for a total value of $10,041,108.51. Following the completion of the sale, the executive vice president directly owned 178,013 shares of the company’s stock, valued at $31,652,491.53. This represents a 24.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.16% of the stock is currently owned by company insiders.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.